Top Analyst Upgrades and Downgrades (AAPL, BHI, BDX, CPHD, CERN, FINL, MCP, QGEN, SD, SAP, TXN, TRV, UN, USNA, USG, YY)

Print Email

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday.

Apple Inc. (NASDAQ: AAPL) cut to Neutral and target cut to $575 from $675 at Citi, and maintained Buy but cut price target to $750 from $800 at Canaccord Genuity.

Baker Hughes Inc. (NYSE: BHI) cut to Equal Weight at Morgan Stanley.

Becton, Dickinson and Co. (NYSE: BDX) started as Underperform at BofA/ML.

Cepheid (NASDAQ: CPHD) started as Buy with $40 target at BoA/ML.

Cerner Corp. (NASDAQ: CERN) started as Buy with $89 target at Argus.

Finish Line Inc. (NASDAQ: FINL) cut to Hold at Canaccord Genuity.

Molycorp Inc. (NYSE: MCP) started as Neutral at Goldman Sachs.

Qiagen N.V. (NASDAQ: QGEN) started as Neutral at BofA/ML.

SandRidge Energy Inc. (NYSE: SD) cut to Sell with $4 target at Canaccord Genuity.

SAP A.G. (NYSE: SAP) raised to Market Perform at JMP Securities.

Texas Instruments Inc. (NASDAQ: TXN) cut to Underperform at Stern Agee.

Travelers Companies Inc. (NYSE: TRV) raised to Top Pick with $87 target at RBC.

Unilever N.V. (NYSE: UN) raised to Neutral from Underperform at Credit Suisse.

USANA Health Sciences Inc. (NYSE: USNA) cut to Hold at Canaccord Genuity.

USG Corp. (NYSE: USG) raised to Top Pick at RBC.

YY Inc. (NASDAQ: YY) started as Sector Perform at Pac-Crest, started as Buy at Citi and started as Overweight at Morgan Stanley.

Here are some other outside (and internal) outlook pieces for the end of 2012 and 2013:

JON C. OGG

RSS Facebook Twitter